Lv11
40 积分 2022-08-29 加入
Overcoming therapy resistance in EGFR-mutant lung cancer
2小时前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
2小时前
已完结
Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study
1个月前
已完结
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
3个月前
已完结
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
7个月前
已完结
Current developments in gastric cancer: from molecular profiling to treatment strategy
7个月前
已完结
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
7个月前
已完结
Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia)
7个月前
已完结
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)
8个月前
已完结
An update to HLA Nomenclature, 2010
8个月前
已完结
皖公网安备34019202002308
